These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 36171595)
1. Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review. Keetharuth AD; Hussain H; Rowen D; Wailoo A Health Qual Life Outcomes; 2022 Sep; 20(1):139. PubMed ID: 36171595 [TBL] [Abstract][Full Text] [Related]
2. Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia. Michalowsky B; Hoffmann W; Xie F J Alzheimers Dis; 2021; 83(1):77-87. PubMed ID: 34275901 [TBL] [Abstract][Full Text] [Related]
3. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia. Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138 [TBL] [Abstract][Full Text] [Related]
4. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report. Fitriana TS; Purba FD; Stolk E; Busschbach JJV Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313 [TBL] [Abstract][Full Text] [Related]
5. Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds. van Heusden A; Rivero-Arias O; Herdman M; Hiscock H; Devlin N; Dalziel K; Pharmacoeconomics; 2024 Jun; 42(Suppl 1):129-145. PubMed ID: 38238604 [TBL] [Abstract][Full Text] [Related]
6. An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care. Easton T; Milte R; Crotty M; Ratcliffe J Qual Life Res; 2018 May; 27(5):1283-1294. PubMed ID: 29305782 [TBL] [Abstract][Full Text] [Related]
7. Assessing the psychometric performance of the EQ-5D-5L among informal caregivers of people with dementia. Sokolova V; Faller J; Asfia SKBM; Engel L Qual Life Res; 2024 Oct; 33(10):2693-2704. PubMed ID: 39046615 [TBL] [Abstract][Full Text] [Related]
8. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA. Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis. Yfantopoulos J; Chantzaras A; Kontodimas S Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371 [TBL] [Abstract][Full Text] [Related]
10. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L. Martin A; Meads D; Griffiths AW; Surr CA Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199 [TBL] [Abstract][Full Text] [Related]
11. Convergent validity of EQ-5D with core outcomes in dementia: a systematic review. Hussain H; Keetharuth A; Rowen D; Wailoo A Health Qual Life Outcomes; 2022 Nov; 20(1):152. PubMed ID: 36403046 [TBL] [Abstract][Full Text] [Related]
12. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness. Bilbao A; García-Pérez L; Arenaza JC; García I; Ariza-Cardiel G; Trujillo-Martín E; Forjaz MJ; Martín-Fernández J Qual Life Res; 2018 Nov; 27(11):2897-2908. PubMed ID: 29978346 [TBL] [Abstract][Full Text] [Related]
13. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression. O'Loughlin R; Jones R; Chen G; Mulhern B; Hiscock H; Devlin N; Dalziel K; Pharmacoeconomics; 2024 Jun; 42(Suppl 1):57-77. PubMed ID: 38329689 [TBL] [Abstract][Full Text] [Related]
14. Validation of the EQ-5D-Y-5L parent-proxy version among children with juvenile idiopathic arthritis. Ohinmaa A; Wen J; Currie GR; Benseler SM; Swart JF; Vastert SJ; Yeung RSM; Marshall DA Qual Life Res; 2024 Oct; 33(10):2677-2691. PubMed ID: 39141175 [TBL] [Abstract][Full Text] [Related]
15. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi. Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714 [TBL] [Abstract][Full Text] [Related]
16. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy. Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637 [TBL] [Abstract][Full Text] [Related]
17. Investigating the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, CHU-9D, and PedsQL in children and adolescents with osteogenesis imperfecta. Xu RH; Zhu L; Sun R; Tan RL; Luo N; Zou S; Dong D Eur J Pediatr; 2022 Dec; 181(12):4049-4058. PubMed ID: 36156120 [TBL] [Abstract][Full Text] [Related]
18. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis. Koszorú K; Hajdu K; Brodszky V; Bató A; Gergely LH; Kovács A; Beretzky Z; Sárdy M; Szegedi A; Rencz F Eur J Health Econ; 2023 Feb; 24(1):139-152. PubMed ID: 35412162 [TBL] [Abstract][Full Text] [Related]
19. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease. Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788 [TBL] [Abstract][Full Text] [Related]
20. Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study. Jones R; O'Loughlin R; Xiong X; Bahrampour M; Devlin N; Hiscock H; Chen G; Mulhern B; Dalziel K; Pharmacoeconomics; 2024 Jun; 42(Suppl 1):39-55. PubMed ID: 37955799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]